comprehensive -WSS

comprehensive

author：leisure time 2025-08-30 08:11:13 - browse：65

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Change Healthcare cyberattack shows risk of industry consolidation

knowledge

WSS

Elisabeth Bik tackles the widespread issue of research misconduct

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Cholera vaccine supplies dangerously low, outbreaks surging

Bird flu surveillance in wastewater gets boost from consortium

Making the case for fair compensation in clinical trials

Neuroscience renaissance leads to new crop of psychiatric drugs

Wikipedia

comprehensive

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

As a primary care physician, here's how I hope to partner with AI

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

How one medical school became remarkably diverse

Ohio train derailment: Experts on toxic chemical risks

Supreme Court strikes down use of affirmative action

Scrutiny of post

Affirmative action in medical school literally saved lives

ASCO eve: Let’s set the table for this year's meeting

Wikipedia

Biogen joins immunology wave with $1.15 billion acquisition of HI

For longer

Scrutiny of post

Biogen joins immunology wave with $1.15 billion acquisition of HI

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

focus

leisure time

knowledge

Wikipedia